Core Laboratories Inc. (NYSE:CLB – Free Report) – Equities research analysts at Zacks Research issued their Q1 2025 earnings per share (EPS) estimates for Core Laboratories in a report released on Wednesday, March 26th. Zacks Research analyst T. Saha forecasts that the oil and gas company will earn $0.15 per share for the quarter. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.83 EPS, Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.28 EPS and FY2026 earnings at $1.04 EPS.
Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%.
Read Our Latest Research Report on CLB
Core Laboratories Stock Down 1.4 %
Shares of NYSE CLB opened at $15.30 on Monday. The firm’s fifty day moving average is $16.44 and its 200 day moving average is $18.11. Core Laboratories has a 52 week low of $12.95 and a 52 week high of $25.13. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. The company has a market cap of $716.45 million, a price-to-earnings ratio of 23.18, a PEG ratio of 0.99 and a beta of 2.38.
Core Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Monday, February 10th were paid a $0.01 dividend. The ex-dividend date was Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.26%. Core Laboratories’s payout ratio is 6.06%.
Hedge Funds Weigh In On Core Laboratories
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Assetmark Inc. purchased a new stake in Core Laboratories during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC grew its holdings in shares of Core Laboratories by 173.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after buying an additional 1,293 shares during the last quarter. Nisa Investment Advisors LLC increased its position in shares of Core Laboratories by 2,688.5% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after acquiring an additional 2,339 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in Core Laboratories by 843.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock worth $57,000 after acquiring an additional 2,936 shares during the last quarter. Finally, BNP Paribas Financial Markets purchased a new position in Core Laboratories in the 4th quarter worth approximately $123,000. Institutional investors own 97.81% of the company’s stock.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Further Reading
- Five stocks we like better than Core Laboratories
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- MarketBeat Week in Review – 03/24 – 03/28
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.